Our Early 2011 report detailed several significant catalysts that resulted in double-digit stock price changes, details of which can be found in the table on Page 2 of this report.

Our Q2 2011 report covers a number of catalysts from 16 drugs and two devices. Additionally, we have included comprehensive calendars through June 2011 from our sister product, CatalystTracker, of Large Impact catalysts in the drug, device/diagnostic and natural resource areas.

For the full report, please download the PDF version at the top of this page.

For our disclosures, please read the BioMedTracker Research Standards.